Arkolith/Insider Trading/IMNM/Form 4

Rosett Max

Chief Financial OfficerImmunome Inc. (IMNM) · full profile →Form 4 · filed Apr 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)32K$1.05$33K79K
Apr 2, 2026Option exercise(M)40K$1.35$54K119K
Apr 2, 2026Sell(S)64K$21.91$1.4M55K
Apr 2, 2026Sell(S)1K$22.48$30K54K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)32K—$060K
Apr 2, 2026Option exercise(M)40K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001994071-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML